Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

Conditions

• HIV Infections

Interventions

• DRUG: Cabotegravir Oral Tablet
• DRUG: TDF/FTC tablets
• DRUG: Placebo for TDF/FTC tablets
• DRUG: Placebo for cabotegravir oral tablet
• DRUG: CAB LA
• DRUG: Placebo for CAB LA

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

• [object Object]
• [object Object]